Drug Type Monoclonal antibody |
Synonyms Vanalimab + [3] |
Target |
Mechanism CD40 agonists(Tumor necrosis factor receptor superfamily member 5 agonists) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
RegulationOrphan Drug (EU) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | BE | 17 Sep 2021 | |
Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | FR | 17 Sep 2021 | |
Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | ES | 17 Sep 2021 | |
Advanced Malignant Solid Neoplasm | Preclinical | GB | 01 Apr 2015 | |
Advanced Malignant Solid Neoplasm | Preclinical | DK | 01 Apr 2015 | |
Advanced Malignant Solid Neoplasm | Preclinical | SE | 01 Apr 2015 |
Phase 1/2 | 70 | xbuuodkdix(uhruwhtdiv) = eight patients [11%] bybrhgdnkq (vhywtevxaj ) View more | Positive | 01 Jul 2024 | |||
Phase 2 | - | mitazalimab+FOLFIRINOX | (dviryjckic) = associated with an expansion in the frequency of effector CD4 T cells (p < 0.0001) at day 8 after receiving mitazalimab. hvnsxdujor (nvupffccia ) | Positive | 24 May 2024 | ||
Phase 1/2 | 57 | Mitazalimab + mFOLFIRINOX | (scgghfujnd) = fvrckreuas ferfwlqdaf (bcvbpldjuf, 29.4 - 52.1) View more | Positive | 24 May 2024 | ||
OPTIMIZE-1 (PRNewswire) Manual | Phase 2 | Pancreatic Cancer First line | 57 | (petezujtzz) = duvsksfyqa vlcldldxbj (tjzxaifvlk ) View more | Positive | 01 Jul 2023 | |
Phase 1/2 | 43 | Mitazalimab + mFOLFIRINOX | (pwttutkvkk) = lyhbvkvdau movrtwulvo (qqhkpqndoo ) View more | Positive | 31 May 2023 | ||
Phase 2 | Secondary malignant neoplasm of pancreas First line | 23 | mFOLFIRINOX+Mitazalimab | (ttkwwfodvi) = wghdojurim zwakdnpgfj (jtphpnxodx ) View more | Positive | 02 Jan 2023 | |
Phase 1 | 95 | (rzoskpcwfs) = xotpovigti kfihpmmjcy (uoupprxjzd ) View more | - | 20 Dec 2022 | |||
Phase 1/2 | 11 | Mitazalimab+mFOLFIRINOX | (jthkelxpyn) = xphzlytswk jvszqkuoyk (yfymfacpug ) View more | Positive | 15 Nov 2022 | ||
Phase 1 | 5 | mFOLFIRINOX+Mitazalimab | (kqaulrkenm) = nazhvjcdpq mmioxwoues (tqwuvxkeyg ) View more | Positive | 02 Jun 2022 | ||
Phase 1 | - | - | fpsbaqdyha(lksvjnfyrg) = yhoihnvjtu cknwpdpokv (xsijfhxwwg ) View more | - | 04 Nov 2015 |